Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
President Donald Trump wrote in a post on Truth Social that talks with Iran “are continuing, at a rapid pace.”
Today, June 1, 2026, investors are weighing a revenue and earnings beat against surging AI infrastructure demand and record trading volume.
James Demmert explains why foreign markets are beating the U.S.—and the five international stocks he thinks can outperform the S&P 500.
Dell Technologies (NYSE:DELL) has become one of the market’s biggest AI winners. The stock has rocketed over 250% year to date and more than 100% in the past month alone, fueled by explosive demand for AI infrastructure. Yet even some bulls are beginning to question how much future growth is already reflected in the share ... Analyst Says Dell’s Momentum Is Real, But Valuation Is Risky with Stock Up 250% YTD
Anthropic, maker of the chatbot Claude, said Monday that it had filed confidential paperwork with federal regulators in preparation for selling its stock to the public. The company is expected to be one of three trillion-dollar debuts on the stock market this year, along with Elon Musk’s rocket and AI venture SpaceX and OpenAI, maker of ChatGPT. SpaceX filed to go public in April and OpenAI is expected to do so soon. (The Washington Post has a content partnership with OpenAI.)Subscribe to The Po
June is finally here and US stocks (^DJI, ^IXIC, ^GSPC) are feeling awfully festive, all three of the major indexes notching new records in the first trading day of the month. Nomura Asset Management chief investment strategist Andy Goldberg looks at why the market's biggest movers are still so concentrated within the AI trade and whether these stock prices are justified.
Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at how the S&P 500 (^GSPC) is performing both with and without leading AI stocks, noting major market events like the ongoing US-Iran war.
Want to celebrate the Dow's 130th birthday? Consider the Invesco Dow Jones Industrial Average Dividend ETF.
Trinity’s 22.9% return over the past six months has outpaced the S&P 500 by 11.9%, and its stock price has climbed to $32.41 per share. This performance may have investors wondering how to approach the situation.
Over the past six months, Hartford’s shares (currently trading at $127.05) have posted a disappointing 6.2% loss, well below the S&P 500’s 10.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Over the last six months, Clorox’s shares have sunk to $90.24, producing a disappointing 15.2% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating their next move.
Crown Holdings has been treading water for the past six months, recording a small loss of 2.3% while holding steady at $95.12. The stock also fell short of the S&P 500’s 10.9% gain during that period.
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. exposure, while the other adds global reach in a sector shaped by drug pricing, patent cycles, regulation, and medical innovation.
SpaceX just filed its S-1 ahead of what could be the largest IPO in history.
The Hanover Insurance Group has been treading water for the past six months, holding steady at $186.29. The stock also fell short of the S&P 500’s 10.9% gain during that period.
Over the past six months, B&G Foods’s shares (currently trading at $4.09) have posted a disappointing 12.2% loss, well below the S&P 500’s 10.9% gain. This might have investors contemplating their next move.
Flagstar Financial has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $14.06 per share while the index has gained 10.9%.
Over the past six months, Guardant Health has been a great trade, beating the S&P 500 by 11.7%. Its stock price has climbed to $129.08, representing a healthy 22.7% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Money-losing tech stocks outpaced major indexes as strategists warn about rising yields and speculation.
Over the past six months, Estée Lauder’s stock price fell to $89.27. Shareholders have lost 5.7% of their capital, which is disappointing considering the S&P 500 has climbed by 10.9%. This may have investors wondering how to approach the situation.
General Dynamics has been treading water for the past six months, recording a small return of 4.5% while holding steady at $347.44. The stock also fell short of the S&P 500’s 10.9% gain during that period.
David Ricks was addressing the pharmaceutical titan's latest hot product.
Nvidia announced its next-gen AI platform and surged 5%. But Apple, Amazon, Tesla, and Meta didn't get invited to the party, and oil prices are up. As a result, the top market indexes barely moved today.
The consumer discretionary sector is split. While McKinsey reports that up to 50% of consumers are cutting big-ticket retail like apparel, the broader slowdown is partially masked by a classic substitution effect: consumers priced out of major luxuries are redirecting cash into affordable, small premium indulgences. [1.
Greg Abel's first big Berkshire deal looks familiar on purpose: cash, housing, and an understandable business. But there's a twist.
Financial institutions play a critical role, offering everything from consumer banking to wealth management and specialized financial solutions. But worries about economic uncertainty and potential market volatility have kept sentiment in check, and over the past six months, the industry’s return was flat while the S&P 500 climbed by 10.9%.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
